• Drugs

  • A Very Short Introduction
  • By: Leslie Iverson
  • Narrated by: Suzanne Toren
  • Length: 4 hrs and 41 mins
  • Unabridged
  • Release date: 11-04-10
  • Language: English
  • Publisher: Audible Studios
  • 3.8 (8 ratings)

Regular price: $11.95

Free with 30-day trial
Membership details Membership details
  • A 30-day trial plus your first audiobook, free
  • 1 credit/month after trial – good for any book, any price
  • Easy exchanges – swap any book you don’t love
  • Keep your audiobooks, even if you cancel
  • After your trial, Audible is just $14.95/month
Select or Add a new payment method

Buy Now with 1 Credit

By confirming your purchase, you agree to Audible's Conditions of Use and Amazon's Privacy Notice. Taxes where applicable.

Buy Now for $11.95

Pay using card ending in
By confirming your purchase, you agree to Audible's Conditions of Use and Amazon's Privacy Notice. Taxes where applicable.

Publisher's Summary

The 20th century saw a remarkable upsurge of research on drugs, with major advances in the treatment of bacterial and viral infections, heart disease, stomach ulcers, cancer, and mental illnesses. These, along with the introduction of the oral contraceptive, have altered all of our lives. There has also been an increase in the recreational use and abuse of drugs in the Western world. This Very Short Introduction gives a non-technical account of how drugs act on the body and how therapeutic drugs are developed and tested, then goes on to review both legal (prescription, alcohol, nicotine, and caffeine) and illegal drugs, and discuss current ideas about why some drugs are addictive, and whether drug laws need reform.
©2001 Leslie Iverson (P)2010 Audible, Inc
Show More Show Less

Customer Reviews

Most Helpful

By Amazon Customer on 06-06-17

An excellent summary

The book was very well written and presented. The information presented were we'll documented. The narrator's pace was excellent and style very pleasant.

Read More Hide me
See all Reviews
© Copyright 1997 - 2018 Audible, Inc